Leo Nissola, M.D. is an immunologist, member of the American Association of Immunologists. Dr. Nissola's work focuses on understanding and fighting advanced-stage cancers with the immune system. He works in early clinical development, designing first-in-human clinical trials for cancer patients and investigating the safety of novel immunotherapy drug combinations to treat cancer.
Dr. Nissola's work is constantly featured at the American Society of Clinical Oncology (ASCO), Society for Immunotherapy of Cancer, and peer-reviewed scientific outlets.
He focuses on clinical data analytics, integrating molecular diagnostics and biological assays for translational medicine strategies. Dr. Nissola has helped design and evaluates data-driven epidemiological models to address the COVID-19 pandemic in America, which the White House Coronavirus Task Force presented in press briefings.
He is known for rapidly incorporating immunotherapy discoveries into innovative clinical trials, including anti-tumor vaccines, checkpoint inhibitors, and first-in-human drug combinations. He has authored adaptive platform clinical protocols, clinical development plans, clinical science data analytics, and medical monitoring plans. He is a member of the American Physician Scientist Association.
Dr. Nissola has helped design and evaluates data-driven epidemiological models to address the COVID-19 pandemic in America, which the White House Coronavirus Task Force presented in press briefings.
Dr. Leo Nissola is a Medical Advisor and served as counsel to various United States legislators and health officials on pandemic response. He frequently appears as a medical expert on American Voices on MSNBC, BBC World News, CBS News, CNN Newsroom, NBC News, and other programs and networks. Dr. Leo Nissola is dedicated to advancing the field of immunology and works to address unmet medical needs. He lives in San Francisco, California.
He is a former medical oncology fellow at the University of Texas MD Anderson Cancer Center in Houston, where he contributed to several cancer studies.
His continued medical education includes translational oncology programs by the German Cancer Consortium, a Cancer Medicine Hematology program at Harvard University in Boston, and a fast-tracked surgical oncology fellowship.
Dr. Nissola is the author of a Systemic Lupus Erythematosus medical textbook and the co-author of several peer-reviewed articles. He lives in San Francisco and is focused on early clinical development.